Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection
Hepatitis delta virus (HDV) coinfects with hepatitis B virus (HBV) causing the most severe form of viral hepatitis. However, its exact global disease burden remains largely obscure. We aim to establish the global epidemiology, infection mode-stratified disease progression, and clinical outcome of HD...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2020
|
| In: |
The journal of infectious diseases
Year: 2019, Volume: 221, Issue: 10, Pages: 1677-1687 |
| ISSN: | 1537-6613 |
| DOI: | 10.1093/infdis/jiz633 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/infdis/jiz633
|
| Author Notes: | Zhijiang Miao, Shaoshi Zhang, Xumin Ou, Shan Li, Zhongren Ma, Wenshi Wang, Maikel P Peppelenbosch, Jiaye Liu, and Qiuwei Pan |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1752916646 | ||
| 003 | DE-627 | ||
| 005 | 20230427070839.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210331r20202019xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/infdis/jiz633 |2 doi | |
| 035 | |a (DE-627)1752916646 | ||
| 035 | |a (DE-599)KXP1752916646 | ||
| 035 | |a (OCoLC)1341402027 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Miao, Zhijiang |e VerfasserIn |0 (DE-588)1230477136 |0 (DE-627)1752917073 |4 aut | |
| 245 | 1 | 0 | |a Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection |c Zhijiang Miao, Shaoshi Zhang, Xumin Ou, Shan Li, Zhongren Ma, Wenshi Wang, Maikel P Peppelenbosch, Jiaye Liu, and Qiuwei Pan |
| 264 | 1 | |c 2020 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online November 28, 2019 | ||
| 500 | |a Gesehen am 31.03.2021 | ||
| 520 | |a Hepatitis delta virus (HDV) coinfects with hepatitis B virus (HBV) causing the most severe form of viral hepatitis. However, its exact global disease burden remains largely obscure. We aim to establish the global epidemiology, infection mode-stratified disease progression, and clinical outcome of HDV infection.We conducted a meta-analysis with a random-effects model and performed data synthesis.The pooled prevalence of HDV is 0.80% (95% confidence interval [CI], 0.63-1.00) among the general population and 13.02% (95% CI, 11.96-14.11) among HBV carriers, corresponding to 48-60 million infections globally. Among HBV patients with fulminant hepatitis, cirrhosis, or hepatocellular carcinoma, HDV prevalence is 26.75% (95% CI, 19.84-34.29), 25.77% (95% CI, 20.62-31.27), and 19.80% (95% CI, 10.97-30.45), respectively. The odds ratio (OR) of HDV infection among HBV patients with chronic liver disease compared with asymptomatic controls is 4.55 (95% CI, 3.65-5.67). Hepatitis delta virus-coinfected patients are more likely to develop cirrhosis than HBV-monoinfected patients with OR of 3.84 (95% CI, 1.79-8.24). Overall, HDV infection progresses to cirrhosis within 5 years and to hepatocellular carcinoma within 10 years, on average.Findings suggest that HDV poses a heavy global burden with rapid progression to severe liver diseases, urging effective strategies for screening, prevention, and treatment. | ||
| 534 | |c 2019 | ||
| 700 | 1 | |a Zhang, Shaoshi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ou, Xumin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Li, Shan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ma, Zhongren |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wang, Wenshi |e VerfasserIn |0 (DE-588)1207849820 |0 (DE-627)1694170705 |4 aut | |
| 700 | 1 | |a Peppelenbosch, Maikel P |e VerfasserIn |4 aut | |
| 700 | 1 | |a Liu, Jiaye |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pan, Qiuwei |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of infectious diseases |d Oxford [u.a.] : Oxford Univ. Press, 1904 |g 221(2020), 10 vom: Mai, Seite 1677-1687 |h Online-Ressource |w (DE-627)269019294 |w (DE-600)1473843-0 |w (DE-576)077662784 |x 1537-6613 |7 nnas |a Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection |
| 773 | 1 | 8 | |g volume:221 |g year:2020 |g number:10 |g month:05 |g pages:1677-1687 |g extent:11 |a Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection |
| 856 | 4 | 0 | |u https://doi.org/10.1093/infdis/jiz633 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210331 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 1207849820 |a Wang, Wenshi |m 1207849820:Wang, Wenshi |d 910000 |d 911700 |e 910000PW1207849820 |e 911700PW1207849820 |k 0/910000/ |k 1/910000/911700/ |p 6 | ||
| 999 | |a KXP-PPN1752916646 |e 3899232895 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"2020"}],"id":{"eki":["1752916646"],"doi":["10.1093/infdis/jiz633"]},"name":{"displayForm":["Zhijiang Miao, Shaoshi Zhang, Xumin Ou, Shan Li, Zhongren Ma, Wenshi Wang, Maikel P Peppelenbosch, Jiaye Liu, and Qiuwei Pan"]},"physDesc":[{"extent":"11 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"1904","publisher":"Oxford Univ. Press ; Univ. of Chicago Press","dateIssuedDisp":"1904-","publisherPlace":"Oxford [u.a.] ; Chicago, Ill."}],"id":{"eki":["269019294"],"zdb":["1473843-0"],"issn":["1537-6613"]},"name":{"displayForm":["publ. for the John Rockefeller McCormick Memorial Fund of the University of Chicago. William H. Taliaferre, ed.-in-chief"]},"pubHistory":["1.1904 -"],"part":{"volume":"221","text":"221(2020), 10 vom: Mai, Seite 1677-1687","extent":"11","year":"2020","issue":"10","pages":"1677-1687"},"note":["Gesehen am 01.03.11"],"disp":"Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infectionThe journal of infectious diseases","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"269019294","language":["eng"],"title":[{"title":"The journal of infectious diseases","subtitle":"medical microbiology, clinical immunology, epidemiology","title_sort":"journal of infectious diseases"}]}],"title":[{"title_sort":"Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection","title":"Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection"}],"person":[{"display":"Miao, Zhijiang","roleDisplay":"VerfasserIn","role":"aut","family":"Miao","given":"Zhijiang"},{"family":"Zhang","given":"Shaoshi","display":"Zhang, Shaoshi","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Ou, Xumin","roleDisplay":"VerfasserIn","given":"Xumin","family":"Ou"},{"family":"Li","given":"Shan","roleDisplay":"VerfasserIn","display":"Li, Shan","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Ma, Zhongren","role":"aut","family":"Ma","given":"Zhongren"},{"family":"Wang","given":"Wenshi","display":"Wang, Wenshi","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Maikel P","family":"Peppelenbosch","role":"aut","display":"Peppelenbosch, Maikel P","roleDisplay":"VerfasserIn"},{"family":"Liu","given":"Jiaye","roleDisplay":"VerfasserIn","display":"Liu, Jiaye","role":"aut"},{"role":"aut","display":"Pan, Qiuwei","roleDisplay":"VerfasserIn","given":"Qiuwei","family":"Pan"}],"note":["Published online November 28, 2019","Gesehen am 31.03.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1752916646","language":["eng"]} | ||
| SRT | |a MIAOZHIJIAESTIMATING2020 | ||